All lobbying filings

Mr. Dan Crippen

Mr. Dan Crippen filed a Q3 report for Amgen on October 1, 2025, reporting $36,000 in lobbying income.

Lobbying for Amgen · Manufacture Pharmaceuticals

As filed: MR. DAN CRIPPEN for AMGEN.

All filings by Mr. Dan Crippen · Everything Amgen has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 1, 2025

Income

$36,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Pharmacy

pharmacy rebates and discounts pharmacy R&D

Economics/Economic Development

pharmacy rebates and discounts

Government Issues

congressional procedure

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.